In contrast to testing NK cells from patients with COVID-19, these NK cells did not exhibit a statistically significant increase in killing with NKG2A blockade but did exhibit increased killing with KIR2DL1 blockade. This evidence concerns the gene KIR2DL1 and COVID-19.